Cell Therapy Market Size, Top Share, Global Trends

Market Segmentation

Cell Therapy Market, By Therapy Type (2022-2034)

Allogenic Therapies
1. Stem Cell Therapies
2. Hematopoietic Stem Cell Therapies
3. Mesenchymal Stem Cell Therapies
4. Non-Stem Cell Therapies
5. Keratinocytes & Fibroblast based therapies
6. Others
Autologous Therapies
1. Stem Cell Therapies
2. BM, Blood, & Umbilical Cord-derived Stem Cells
3. Adipose Derived Cells
4. Others
Non-Stem Cell Therapies
1. T Cell Therapies
2. CAR T Cell Therapy
3. T cell Receptor based
4. Others

Cell Therapy Market, By Therapeutic Area (2022-2034)

Oncology
Cardiovascular Disease
Musculoskeletal Disorders
Dermatology
Others

Cell Therapy Market, By Manufacturers (2022-2034)

Biopharmaceutical and biotechnology companies
Pharmaceutical companies
CDMOs/CMOs
Others

Regional Cell Therapy Market

North America
1. North America Cell Therapy Market, By Therapy Type
  1. Allogenic Therapies
  2. Autologous Therapies
  3. Non-Stem Cell Therapies
2. North America Cell Therapy Market, By Therapeutic Area
  1. Oncology
  2. Cardiovascular Disease
  3. Musculoskeletal Disorders
  4. Dermatology
  5. Others
3. North America Cell Therapy Market, By Manufacturers
  1. Biopharmaceutical and biotechnology companies
  2. Pharmaceutical companies
  3. CDMOs/CMOs
  4. Others
4. U.S.
  1. U.S. Cell Therapy Market, By Therapy Type
    1. Allogenic Therapies
    2. Autologous Therapies
    3. Non-Stem Cell Therapies
  2. U.S. Cell Therapy Market, By Therapeutic Area
    1. Oncology
    2. Cardiovascular Disease
    3. Musculoskeletal Disorders
    4. Dermatology
    5. Others
  3. U.S. Cell Therapy Market, By Manufacturers
    1. Biopharmaceutical and biotechnology companies
    2. Pharmaceutical companies
    3. CDMOs/CMOs
    4. Others
5. Canada
Europe
1. Europe Cell Therapy Market, By Therapy Type
  1. Allogenic Therapies
  2. Autologous Therapies
  3. Non-Stem Cell Therapies
2. Europe Cell Therapy Market, By Therapeutic Area
  1. Oncology
  2. Cardiovascular Disease
  3. Musculoskeletal Disorders
  4. Dermatology
  5. Others
3. Europe Cell Therapy Market, By Manufacturers
  1. Biopharmaceutical and biotechnology companies
  2. Pharmaceutical companies
  3. CDMOs/CMOs
  4. Others
4. U.K.
  1. U.K. Cell Therapy Market, By Therapy Type
    1. Allogenic Therapies
    2. Autologous Therapies
    3. Non-Stem Cell Therapies
  2. U.K. Cell Therapy Market, By Therapeutic Area
    1. Oncology
    2. Cardiovascular Disease
    3. Musculoskeletal Disorders
    4. Dermatology
    5. Others
  3. U.K. Cell Therapy Market, By Manufacturers
    1. Biopharmaceutical and biotechnology companies
    2. Pharmaceutical companies
    3. CDMOs/CMOs
    4. Others
5. Germany
6. France
7. Spain
8. Italy
9. Russia
10. Nordic
11. Benelux
12. Rest of Europe
APAC
1. APAC Cell Therapy Market, By Therapy Type
  1. Allogenic Therapies
  2. Autologous Therapies
  3. Non-Stem Cell Therapies
2. APAC Cell Therapy Market, By Therapeutic Area
  1. Oncology
  2. Cardiovascular Disease
  3. Musculoskeletal Disorders
  4. Dermatology
  5. Others
3. APAC Cell Therapy Market, By Manufacturers
  1. Biopharmaceutical and biotechnology companies
  2. Pharmaceutical companies
  3. CDMOs/CMOs
  4. Others
4. China
  1. China Cell Therapy Market, By Therapy Type
    1. Allogenic Therapies
    2. Autologous Therapies
    3. Non-Stem Cell Therapies
  2. China Cell Therapy Market, By Therapeutic Area
    1. Oncology
    2. Cardiovascular Disease
    3. Musculoskeletal Disorders
    4. Dermatology
    5. Others
  3. China Cell Therapy Market, By Manufacturers
    1. Biopharmaceutical and biotechnology companies
    2. Pharmaceutical companies
    3. CDMOs/CMOs
    4. Others
5. Korea
6. Japan
7. India
8. Australia
9. Singapore
10. Taiwan
11. South East Asia
12. Rest of Asia-Pacific
Middle East and Africa
1. Middle East and Africa Cell Therapy Market, By Therapy Type
  1. Allogenic Therapies
  2. Autologous Therapies
  3. Non-Stem Cell Therapies
2. Middle East and Africa Cell Therapy Market, By Therapeutic Area
  1. Oncology
  2. Cardiovascular Disease
  3. Musculoskeletal Disorders
  4. Dermatology
  5. Others
3. Middle East and Africa Cell Therapy Market, By Manufacturers
  1. Biopharmaceutical and biotechnology companies
  2. Pharmaceutical companies
  3. CDMOs/CMOs
  4. Others
4. UAE
  1. UAE Cell Therapy Market, By Therapy Type
    1. Allogenic Therapies
    2. Autologous Therapies
    3. Non-Stem Cell Therapies
  2. UAE Cell Therapy Market, By Therapeutic Area
    1. Oncology
    2. Cardiovascular Disease
    3. Musculoskeletal Disorders
    4. Dermatology
    5. Others
  3. UAE Cell Therapy Market, By Manufacturers
    1. Biopharmaceutical and biotechnology companies
    2. Pharmaceutical companies
    3. CDMOs/CMOs
    4. Others
5. Turkey
6. Saudi Arabia
7. South Africa
8. Egypt
9. Nigeria
10. The rest of MEA
LATAM
1. LATAM Cell Therapy Market, By Therapy Type
  1. Allogenic Therapies
  2. Autologous Therapies
  3. Non-Stem Cell Therapies
2. LATAM Cell Therapy Market, By Therapeutic Area
  1. Oncology
  2. Cardiovascular Disease
  3. Musculoskeletal Disorders
  4. Dermatology
  5. Others
3. LATAM Cell Therapy Market, By Manufacturers
  1. Biopharmaceutical and biotechnology companies
  2. Pharmaceutical companies
  3. CDMOs/CMOs
  4. Others
4. Brazil
  1. Brazil Cell Therapy Market, By Therapy Type
    1. Allogenic Therapies
    2. Autologous Therapies
    3. Non-Stem Cell Therapies
  2. Brazil Cell Therapy Market, By Therapeutic Area
    1. Oncology
    2. Cardiovascular Disease
    3. Musculoskeletal Disorders
    4. Dermatology
    5. Others
  3. Brazil Cell Therapy Market, By Manufacturers
    1. Biopharmaceutical and biotechnology companies
    2. Pharmaceutical companies
    3. CDMOs/CMOs
    4. Others
5. Mexico
6. Argentina
7. Chile
8. Colombia
9. Rest of LATAM